Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN002017 | 54.01 | 6.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 54.01 | 6.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 54.01 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 58.06 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 58.06 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.05 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.08 | 4.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 60.08 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.01 | 3.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Urea | 61.0398 | 2.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 61.04 | 2.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.04 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 61.04 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 7.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 70.06 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 72.08 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 74.06 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Isobutylamine | 74.0954 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 74.1 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 74.1 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 75.1 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glycine | 76.0383 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Trimethylamine N-oxide | 76.0752 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 79.02 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 80.05 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 80.05 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 83.06 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.04 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.04 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.08 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 84.96 | 9.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-TMAO iSTD | 85.1319 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 86.06 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.06 | 2.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.07 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 86.1 | 6.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.07 | 1.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 4.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 88.11 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 89.06 | 1.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | beta-Alanine | 90.0539 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 90.98 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 91.07 | 2.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 93.06 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-DL-Alanine iSTD | 93.0728 | 7.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Picoline | 94.0646 | 4.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 2-Aminopyridine | 95.0594 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 96.04 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 1.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 96.04 | 2.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Pyridone | 96.0446 | 2.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 100.07 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 101.11 | 3.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 101.11 | 3.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 2.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 2.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.05 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 2.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 102.13 | 3.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.05 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.13 | 3.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 103.79 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 104.11 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 104.11 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Serine | 106.0486 | 8.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylaniline | 108.0791 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 108.08 | 3.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 108.08 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 108.08 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.01 | 9.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.07 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 110.07 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-.alpha.-(tert-Butoxycarbonyl)-L-histidine | 110.0702 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 112 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112 | 9.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112.01 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 112.05 | 6.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 113.03 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 113.07 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Choline iSTD | 113.1634 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 113.72 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 114.06 | 3.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Creatinine | 114.0662 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 115.05 | 3.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.09 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.09 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 115.12 | 2.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Proline | 116.0694 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 116.07 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.07 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.07 | 13.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.12 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 116.14 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ketoisovaleric acid | 117.0534 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 117.07 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Creatinine iSTD | 117.0847 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 117.73 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Betaine | 118.0862 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 118.09 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 118.09 | 7.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 119.1 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 120.06 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Homoserine | 120.0639 | 8.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Threonine | 120.0642 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 120.08 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 120.1 | 5.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.07 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.09 | 2.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.09 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.1 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 122.92 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 123.05 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Nicotinic acid | 124.0384 | 4.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 124.92 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 125.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 125.98 | 9.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.02 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Taurine | 126.0212 | 7.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 126.09 | 1.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 126.09 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 127.07 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 127.07 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Betaine iSTD | 127.1424 | 6.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Dihydro-4,4-dimethyl-2,3-furandione | 129.0531 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 129.07 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Histamine, N-methyl- iSTD | 129.1202 | 7.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 129.14 | 1.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 129.14 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyroglutamic acid | 130.0488 | 8.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 130.05 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.06 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.08 | 6.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylproline | 130.085 | 6.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Pipecolic acid | 130.0855 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 130.09 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.09 | 8.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.09 | 9.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.1 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 1.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 130.16 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.05 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.12 | 6.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 131.68 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.06 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Hydroxyproline | 132.0632 | 7.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 132.07 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 5.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 5.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.08 | 7.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.1 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 132.1 | 7.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Isoleucine | 132.101 | 6.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Norleucine | 132.1012 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 133.09 | 7.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ornithine | 133.0957 | 9.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Aspartic acid | 134.0432 | 8.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxybenzylcyanide | 134.0591 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 6-Aminoindazole | 134.0697 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 134.09 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 134.12 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-Creatine iSTD | 135.0951 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 136.04 | 1.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 1.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.04 | 2.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.05 | 4.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.05 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 136.06 | 2.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Adenine | 136.0603 | 4.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 136.07 | 7.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 137.04 | 4.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 137.04 | 4.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hypoxanthine | 137.0452 | 4.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D3-DL-Aspartic acid iSTD | 137.0625 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 138.05 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 138.05 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 138.05 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Aminobenzoic acid | 138.0536 | 7.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Imidazoleacrylic acid | 139.0487 | 3.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Urocanic acid | 139.0502 | 3.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 140.05 | 2.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.05 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Deferiprone | 140.0692 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 140.07 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.08 | 4.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 140.08 | 4.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-1-Methylnicotinamide iSTD | 140.0895 | 6.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 141.06 | 7.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.02 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 2.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.05 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 142.08 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.08 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.08 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 143.12 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Methyl-5-thiazoleethanol? | 144.0463 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 144.1 | 6.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.1 | 7.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.1 | 13.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N.alpha.-Methyl-L-lysine | 144.1005 | 6.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 144.17 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.17 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 144.17 | 1.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.05 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.1 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 145.1 | 7.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ethylhexanoate | 145.1208 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 145.13 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.02 | 4.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.03 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.06 | 6.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Acetamidobutyric acid | 146.0799 | 2.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 146.08 | 2.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Guanidinobutyric acid | 146.0897 | 7.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylisoleucine | 146.1161 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | (3-Carboxypropyl)trimethylammonium | 146.1162 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 146.12 | 2.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 146.12 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutamine | 147.0758 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 147.11 | 8.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 147.11 | 8.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Lysine | 147.112 | 9.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Trimethylammoniobutanoic acid | 147.1197 | 7.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 148 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 148 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutamic acid | 148.0592 | 8.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | (+)-Pseudoephedrine | 148.1114 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxy-3-methoxymandelic acid | 149.0222 | 0.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Dihydrocoumarin | 149.0576 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 4-Hydroxymandelonitrile | 150.0566 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Methionine | 150.0573 | 7.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 150.1 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 150.14 | 2.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.03 | 9.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.05 | 8.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-DL-Glutamic acid iSTD | 151.0785 | 8.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 151.09 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 2.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 4.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 151.09 | 4.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Guanine | 152.0553 | 6.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Acetaminophen | 152.0689 | 1.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D5-L-Glutamine iSTD | 152.107 | 8.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 153.06 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Crotonobetaine iSTD | 153.1583 | 7.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Creatine | 154.057 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 154.12 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.04 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.04 | 8.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 155.15 | 1.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D9-Butyrobetaine iSTD | 155.1739 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 156.04 | 6.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.04 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 2.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.06 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Histidine | 156.0756 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 156.08 | 8.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.08 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.08 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.1 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 156.1 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.08 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.08 | 4.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.1 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 157.17 | 1.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 158.12 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 158.96 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.03 | 4.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.06 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.07 | 4.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.08 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.08 | 4.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.15 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 159.15 | 8.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.03 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.03 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.04 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.06 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.07 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Betonicine | 160.0955 | 7.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 160.13 | 5.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.13 | 6.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.13 | 6.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 160.2 | 5.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.06 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methyllysine | 161.1273 | 9.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 161.13 | 7.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.62 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 161.62 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylglutamic acid | 162.0744 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 162.1 | 2.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.1 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 162.11 | 7.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Carnitine | 162.112 | 7.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 163.12 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 164.03 | 7.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.01 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.05 | 7.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 2.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.1 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.11 | 2.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 165.11 | 2.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-L-Carnitine iSTD | 165.131 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Methioninesulfoxide A | 166.0516 | 8.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 166.07 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylalanine | 166.0862 | 6.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 166.09 | 6.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 167.08 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Carbamic acid, N-(2,2-diphenylacetyl)-, ethyl ester | 167.0847 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 168.06 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyridoxal | 168.0641 | 1.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Vanillic acid | 169.057 | 8.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 169.06 | 8.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.17 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.19 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 169.98 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pyridoxine | 170.0796 | 3.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 170.08 | 3.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 6.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 9.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.09 | 9.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Methylhistidine | 170.0918 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Methylhistidine | 170.0924 | 8.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 170.12 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 170.12 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 171.07 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 172.13 | 7.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.07 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.08 | 5.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.08 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 173.09 | 7.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.01 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.11 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 174.11 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.03 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.03 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.05 | 2.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.1 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.11 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 175.11 | 8.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Arginine | 175.1187 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 175.14 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 176.09 | 7.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Citrulline | 176.1017 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 177.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 177.09 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 177.09 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Serotonin | 177.1004 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 15N2-L-Arginine iSTD | 177.1114 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 178.08 | 6.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.08 | 6.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.08 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 2.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 3.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 178.13 | 3.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.05 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | trans-Nicotine-1'-oxide | 179.1164 | 6.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 179.12 | 1.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.12 | 6.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 179.13 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.05 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hippuric acid | 180.0636 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Galactosamine | 180.0865 | 8.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | beta-Homophenylalanine | 180.0998 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 180.1 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 180.1 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Methylphenylalanine | 180.1003 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 181.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 181.05 | 4.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Theobromine | 181.0705 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Paraxanthine | 181.0705 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 182.06 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tyrosine | 182.0795 | 7.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 182.08 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.08 | 1.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.1 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 182.96 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 183.18 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.05 | 6.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 4-Pyridoxate | 184.059 | 2.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 184.07 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3,5-Dihydroxyphenylglycine | 184.0703 | 8.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Phosphocholine | 184.0718 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 184.09 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.09 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 184.1 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.08 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.09 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.09 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.1 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.12 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.13 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 185.13 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 186.11 | 6.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ecgonine | 186.1111 | 7.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 186.15 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 186.22 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 8.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 9.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.07 | 9.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.1 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.11 | 7.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 187.13 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.07 | 5.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.08 | 4.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 7.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.13 | 7.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 188.17 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N8-Acetylspermidine | 188.1744 | 8.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 189.07 | 4.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.07 | 4.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.07 | 4.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 189.09 | 9.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-epsilon-Acetyllysine | 189.122 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Gly-Leu | 189.1222 | 7.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Homoarginine | 189.1331 | 9.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-trimethyllysine | 189.1586 | 8.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 3-Indolepropionic acid | 190.085 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 191.04 | 8.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2,6-Diaminopimelic acid | 191.1021 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 192.08 | 3.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.09 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.09 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.1 | 6.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 192.12 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.1 | 2.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 193.13 | 1.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tocainide | 193.1415 | 4.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Phenylacetylglycine | 194.0817 | 2.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 194.1 | 7.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 194.1 | 7.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Caffeine | 195.0863 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 195.1 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 195.12 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 196.06 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 196.06 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Deoxy-1-(methylamino)-D-galactitol | 196.1167 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 3-Aminotyrosine | 197.088 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 197.2 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 198.07 | 4.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetylhistidine | 198.085 | 7.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 198.09 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 198.09 | 8.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.07 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.14 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.17 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 199.17 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 200.13 | 6.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 201.98 | 7.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 202.07 | 8.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 202.11 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 7.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.05 | 8.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ser-Pro | 203.1124 | 8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Ala-Ile | 203.1379 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N,N-Dimethylarginine | 203.1494 | 8.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 203.15 | 8.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 203.5 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Acetyl-L-carnitine | 204.1213 | 12.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Acetylcarnitine | 204.123 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | D9-Caffeine iSTD | 204.1438 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 205.09 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Tryptophan | 205.0958 | 6.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 206.05 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.05 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.14 | 6.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 206.89 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | D3-AC(2:0) iSTD | 207.1417 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 207.21 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.01 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.01 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.11 | 1.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 208.88 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Kynurenine | 209.0904 | 6.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 209.2 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.01 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.1 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.1 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.11 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 210.12 | 5.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pro-Pro | 213.1211 | 7.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 214.92 | 10.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 215.07 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Chlorotyrosine | 216.0402 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 216.06 | 8.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 216.12 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 216.91 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Diphenylmethylphosphine oxide | 217.0759 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.08 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 6-Methoxynaphthaleneacetic acid | 217.0852 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.1 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-.alpha.-Acetyl-L-arginine | 217.128 | 7.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 217.18 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 217.18 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 218.1 | 2.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Propionylcarnitine | 218.1386 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 218.91 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 219.1 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 219.1 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetyl-5-hydroxytryptamine | 219.1126 | 3.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Pantothenic acid | 220.1173 | 3.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 220.12 | 3.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 220.12 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 221.15 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.07 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.17 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.17 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.99 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 223.99 | 9.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 225.03 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.04 | 7.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.04 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 226.95 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.08 | 2.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.08 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.11 | 4.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 227.21 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.02 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.02 | 7.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 228.03 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2'-Deoxycytidine | 228.0965 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 229.08 | 2.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Deoxyuridine | 229.084 | 2.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 229.11 | 4.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.11 | 4.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.12 | 8.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 229.15 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ergothioneine | 230.0939 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 230.25 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 231.09 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Naproxen | 231.101 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 231.12 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 3.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 5.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.08 | 6.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 232.09 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | (R)-Butyrylcarnitine | 232.1542 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 232.93 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.06 | 8.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.08 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.09 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 233.09 | 1.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 234.11 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.09 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.17 | 1.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 235.18 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 236.07 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 239.06 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Gly-Tyr | 239.1043 | 7.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 240.1 | 5.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.15 | 1.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.16 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 240.86 | 13.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cystine | 241.0296 | 9.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 241.1 | 2.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.15 | 7.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | cis-lambda-Viniferin | 241.1781 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 241.18 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.18 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.19 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 241.23 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.1 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.1 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 242.64 | 9.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cytidine | 244.092 | 6.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 244.13 | 8.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.15 | 5.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 244.22 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.07 | 7.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Pseudouridine | 245.0749 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Biotin | 245.0974 | 2.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 245.1 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.1 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 245.98 | 3.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.14 | 3.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.15 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2-Methylbutyryl-L-carnitine | 246.1693 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 246.18 | 9.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 246.18 | 9.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.09 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 247.15 | 5.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.11 | 8.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.13 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.13 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3-Hydroxybutyrylcarnitine | 248.1487 | 7.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 248.15 | 5.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 248.15 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 249.11 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 249.18 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.09 | 2.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.09 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 250.1 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.13 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.2 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 251.21 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.03 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.08 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.11 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.12 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 1.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 1.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.13 | 2.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 252.15 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 253.12 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 253.13 | 6.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Sulfamethoxazole | 254.058 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 254.14 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 254.14 | 1.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.04 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.21 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 255.94 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 256.19 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 257.15 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 257.32 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 258.07 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 2'-O-Methylcytidine | 258.1068 | 4.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 258.2 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 259.19 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 259.19 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 260.15 | 6.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Hexanoyl-L-carnitine | 260.1845 | 4.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 261.1 | 7.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma-Glutamylleucine | 261.1431 | 7.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 261.15 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.2 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.21 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 261.21 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 262.14 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Asp-Glu | 263.0859 | 9.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 263.17 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 264.19 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 265.11 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 265.11 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylacetylglutamine | 265.119 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 266.16 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.16 | 7.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.17 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 266.2 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.07 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.08 | 2.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 267.19 | 1.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 268.1 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 8-Oxo-2-deoxyadenosine | 268.1034 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Adenosine | 268.1045 | 4.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 268.26 | 4.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 268.26 | 4.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Inosine | 269.0868 | 6.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | N-Acetyl-L-carnosine | 269.123 | 8.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 269.2 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 273.12 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 273.17 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.01 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.27 | 1.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 274.27 | 1.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 275.16 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma-Glutamylglutamine | 276.1178 | 9.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 276.18 | 6.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | gamma.-Glutamyl-L-glutamic acid | 277.1013 | 9.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 277.18 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.19 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.21 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 277.21 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 278.16 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.09 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.23 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 279.69 | 8.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 280.15 | 5.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Linoleic acid | 281.2459 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 281.25 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.05 | 6.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Methyladenosine B | 282.1189 | 7.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 282.14 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.18 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 282.28 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 283.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 3'-O-Methylinosine | 283.1049 | 4.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 283.19 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 284.33 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 285.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 285.13 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Piperine | 286.1422 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 286.2 | 4.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 286.2 | 4.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Heptadecasphing-4-enine | 286.2729 | 4.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 287.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Phenylacetyl-L-glutamine | 287.0996 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 287.21 | 4.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.15 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.21 | 3.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.22 | 4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 288.22 | 4.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 289.24 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 290.85 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Trimethoprim | 291.1436 | 4.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 291.18 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.18 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.23 | 3.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.23 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.24 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.25 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 291.97 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 292.2 | 9.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 292.84 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 9.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.1 | 10.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.11 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.14 | 8.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 293.22 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.1 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.11 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.84 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 294.94 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.06 | 4.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.06 | 4.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.07 | 4.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.1 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.22 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.22 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.23 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 295.23 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 296.01 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 296.01 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N-Acetylsulfamethoxazole | 296.0682 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 296.22 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.08 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.15 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.15 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.24 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 297.24 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 298.02 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cysteine-glutathione disulfide | 298.051 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 5'-S-Methyl-5'-thioadenosine | 298.0974 | 1.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 298.1 | 1.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 298.1 | 1.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1-Methylguanosine | 298.1131 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 298.18 | 8.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ethylhexadecyldimethylammonium cation | 298.3451 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 299.14 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 299.26 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.09 | 1.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.25 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 300.25 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 301.12 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Desmethylranitidine | 301.1313 | 5.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 301.15 | 6.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Retinoic acid | 301.2142 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 303.19 | 6.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.21 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.21 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 304.3 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 305.96 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 307.03 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 307.17 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutathione (reduced) | 308.0907 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 308.15 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 308.21 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Dihydrocapsaicin | 308.2183 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 308.28 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.05 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.12 | 2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.13 | 8.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.15 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 309.99 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.02 | 9.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 3.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 4.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.2 | 4.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 310.31 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | N2,N2-Dimethylguanosine | 312.1286 | 5.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 313.14 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.16 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.23 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 313.24 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.07 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.1 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.18 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 314.23 | 3.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.08 | 10.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.08 | 10.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.1 | 2.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.12 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.13 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.13 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ranitidine | 315.1487 | 4.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 315.15 | 4.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 315.19 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Octadecanedioic acid | 315.2516 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 316.07 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.08 | 9.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 316.25 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 8.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 9.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 9.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 10.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 13.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.05 | 13.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 8.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.06 | 9.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.19 | 1.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.19 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.19 | 4.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 317.27 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 318.06 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 319.13 | 5.77 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 319.13 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 321.2 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 321.31 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 324.21 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 324.21 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 324.22 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 324.22 | 6.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Uridine 5'-monophosphate | 325.0422 | 8.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 325.11 | 8.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 325.11 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 325.11 | 8.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 327.2 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 327.21 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 327.22 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 328.28 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 329.23 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 329.24 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 330.07 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 330.26 | 6.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.03 | 8.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.04 | 9.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.04 | 9.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.04 | 9.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.04 | 9.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.04 | 10.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.05 | 9.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.09 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Ranitidine N-oxide | 331.1427 | 5.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 331.2 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.2 | 3.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.2 | 3.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.2 | 3.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.2 | 3.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.2 | 3.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.25 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 331.25 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 332.19 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 332.2 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 332.24 | 4.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 332.24 | 5.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 332.33 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 333.09 | 3.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 333.09 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 333.09 | 3.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 333.3 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 8.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 8.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 8.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 8.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 9.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 9.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 334.08 | 9.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 335.1 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 335.22 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 335.28 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 336.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.01 | 9.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.05 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.06 | 9.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.23 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.23 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 337.23 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 338.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Erucamide | 338.3416 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 339.18 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 340.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 341.18 | 5.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | CUDA iSTD | 341.2806 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 342.04 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 343.15 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 343.28 | 4.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 343.29 | 4.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | CocamidoprpylBetaine | 343.2941 | 4.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 344.23 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 344.24 | 1.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Lauroyl-L-carnitine | 344.2793 | 2.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 344.28 | 2.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 344.28 | 2.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 344.87 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 345.08 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 345.09 | 6.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 345.23 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 345.23 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 8.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 9.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 10.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 10.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 10.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 10.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 346.01 | 11.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.01 | 8.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.01 | 9.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.01 | 10.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.01 | 10.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.01 | 10.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 347.02 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cortodoxone | 347.22 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Corticosterone | 347.2202 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 2'-Deoxyguanosine 5'-monophosphate | 348.0684 | 8.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Adenosine 5'-monophosphate | 348.0687 | 8.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 348.87 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Inosine-5'-monophosphate | 349.0529 | 9.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 349.12 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 349.2 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 350.32 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 351.21 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 351.21 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 351.21 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 351.21 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 352.3 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 353.11 | 6.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 353.11 | 7.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 353.12 | 7.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 353.23 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 353.23 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 354.01 | 9.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 354.23 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 354.26 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 355.01 | 9.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.15 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.21 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 1.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 1.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 1.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 2.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.22 | 2.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.23 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 356.35 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.01 | 9.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.01 | 9.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.09 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.22 | 2.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.24 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 357.25 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 358.01 | 9.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Indomethacin | 358.0836 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 358.2 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 358.21 | 5.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 359.01 | 9.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 359.22 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 359.22 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Trehalose | 360.1479 | 8.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Turanose | 360.148 | 8.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | Sucrose | 360.1483 | 8.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 360.15 | 8.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 360.32 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 360.36 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 361.01 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 361.18 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glu-Gly-Arg | 361.183 | 8.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 362.02 | 7.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 362.88 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 362.93 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 8.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 8.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.03 | 10.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.04 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.04 | 9.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 363.04 | 9.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 364 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Guanosine 5'-monophosphate | 364.0631 | 9.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 364.19 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 364.19 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 365.07 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 365.07 | 7.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 365.1 | 8.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 365.1 | 8.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Isomaltose | 365.1037 | 8.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 365.39 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 366.37 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 367.21 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 367.21 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 368.28 | 2.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 369.25 | 8.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 369.35 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 369.35 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.05 | 8.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.29 | 1.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.29 | 1.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.29 | 1.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.29 | 1.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 370.29 | 1.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 371.23 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 371.31 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 371.31 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 372.24 | 1.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 372.35 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 374.32 | 1.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 374.81 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.02 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.19 | 8.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.21 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.33 | 1.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.33 | 2.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.33 | 2.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 375.93 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 376.21 | 5.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 376.8 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 377.06 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 377.93 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 378.24 | 6.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 379.19 | 4.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 379.19 | 4.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Val-Tyr-Val iSTD | 380.218 | 6.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 381.3 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 382.3 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 383.04 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 383.15 | 4.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 385.04 | 9.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | S-Adenosyl-homocysteine | 385.1272 | 8.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 385.9 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 388.25 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 388.34 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Benzyldimethylstearylammonium cation | 388.3912 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 389.12 | 9.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 389.12 | 9.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 389.12 | 9.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 389.12 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 389.16 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cetirizine | 389.1609 | 1.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 389.22 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 389.27 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 391.28 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 392.16 | 4.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 392.16 | 4.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 392.22 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 393.3 | 0.89 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 393.3 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 393.3 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 394.21 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Bisphenol A bis(2,3-dihydroxypropyl) ether | 394.2206 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 397.16 | 7.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 398.29 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 398.32 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 398.32 | 1.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 398.32 | 1.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 399.25 | 0.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 399.31 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 400.34 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 400.34 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 400.34 | 1.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 400.38 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 401.05 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 401.34 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 401.34 | 1.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 402.23 | 5.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 402.36 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Dehydrocholic acid | 403.2568 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 403.26 | 3.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 403.26 | 3.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 403.26 | 3.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 403.26 | 3.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 405.01 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 405.37 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Galacto-N-biose | 406.1299 | 8.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 406.13 | 7.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 407.28 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 408.29 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 408.31 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 409.27 | 13.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 409.29 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 409.85 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 413.03 | 9.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 415 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 415.25 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 416.2 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 416.33 | 4.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 416.34 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 417.26 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 417.33 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 418.17 | 6.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 418.17 | 6.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 418.23 | 5.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 418.55 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 419.21 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 419.23 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 419.31 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 419.55 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.19 | 3.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.19 | 3.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.19 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.19 | 3.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.22 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.22 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 420.33 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 421.33 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 422.32 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 424.16 | 5.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 424.16 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 424.16 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 424.34 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Linoleoylcarnitine | 424.3405 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 426.22 | 0.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 426.32 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 426.36 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 427.3 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 427.3 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 428.03 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 428.11 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 428.37 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 429 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 429.37 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 430.91 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 431.24 | 5.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 431.31 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 431.98 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 432.24 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 432.28 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 432.92 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 433.15 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 433.37 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 434 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 435.34 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 435.34 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 436.34 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 436.34 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 437.24 | 4.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 437.32 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 438.22 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 438.3 | 5.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 439.34 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 439.34 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 439.35 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 439.38 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 440.34 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.1 | 8.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.17 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.17 | 4.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.32 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.32 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.36 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.36 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.93 | 7.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 441.93 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 443.98 | 9.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 444.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 444.07 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 445.21 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 445.29 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 445.33 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 446.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 446.26 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 446.26 | 5.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 447.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cytidine 5'-diphosphate ethanolamine | 447.0644 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 447.34 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 448.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 449.36 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 449.36 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.27 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 2.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 4.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 450.32 | 4.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 451.05 | 8.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 451.32 | 4.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 451.37 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 453.35 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 453.36 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 453.36 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 454.29 | 5.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 454.29 | 5.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 455.14 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 455.34 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 455.37 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 456.1 | 8.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 456.12 | 6.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 456.37 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 456.37 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 456.37 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 458.77 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 459.27 | 5.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 459.37 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 460.77 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 461.02 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 461.18 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 461.21 | 3.72 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 461.32 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 463.22 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 463.34 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 463.34 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.12 | 6.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.19 | 6.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.19 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.3 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.37 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 464.38 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 465.35 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 465.36 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.26 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.27 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.27 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.29 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.29 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.29 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.29 | 5.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glycocholic acid | 466.3143 | 5.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 466.32 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.32 | 5.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.33 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.33 | 5.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.38 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 466.38 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.26 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.34 | 4.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.35 | 3.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.35 | 3.91 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.35 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 467.37 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 468.31 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 468.32 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 469.19 | 3.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 469.31 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 469.39 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 471.11 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 472.3 | 2.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 472.3 | 3.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glycodeoxycholic acid | 472.3004 | 4.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 472.36 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 473.36 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 473.36 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 473.36 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 474.83 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 475.26 | 5.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 475.26 | 5.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 475.37 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 475.38 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 476.3 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.12 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.32 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.32 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.32 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.39 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 477.39 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.06 | 8.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.29 | 5.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.29 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.32 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.33 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.82 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 478.97 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 479.33 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 480.31 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 480.31 | 5.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 480.31 | 5.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 480.36 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 480.37 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 481.35 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 481.35 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 482.06 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 482.38 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.19 | 3.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.19 | 3.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.32 | 5.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.33 | 5.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.34 | 5.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.36 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.36 | 5.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.37 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 483.38 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 484.27 | 9.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 484.38 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 484.4 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 485.32 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 485.32 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 485.38 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 486.22 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 486.32 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 486.41 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 486.41 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 487.34 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 487.4 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 488.32 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 488.36 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Cytidine 5'-diphosphocholine | 489.1123 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 489.18 | 2.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 489.35 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 490.28 | 5.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 491.37 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 491.37 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 492.08 | 8.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 492.11 | 9.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 492.24 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 493.09 | 8.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 493.39 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 494.32 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 494.39 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 494.81 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 495.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 495.4 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 496.34 | 5.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 496.41 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 496.99 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 497.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 497.34 | 5.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 497.42 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 498.37 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 498.38 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 498.9 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 498.92 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 499.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 499.97 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 500.3 | 4.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 500.39 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 500.39 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.34 | 0.97 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.34 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.39 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.39 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 501.98 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.29 | 5.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.29 | 5.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.29 | 5.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.34 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.41 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 502.67 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.06 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.3 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.3 | 5.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.33 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.34 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.41 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 503.41 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 504.38 | 1.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Maltotriose | 505.1732 | 9.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 505.35 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 505.35 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 505.43 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 507.35 | 5.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 507.36 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 507.36 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 508.34 | 5.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 508.34 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 508.36 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 508.4 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 508.4 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 509.26 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 509.33 | 6.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 509.35 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 509.38 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 509.92 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 510.41 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 511.16 | 2.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 511.16 | 2.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 511.3 | 4.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 511.4 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 512.33 | 5.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 512.33 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 513.35 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 513.35 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 513.41 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 513.43 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 515.37 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Didodecyl 3,3'-thiodipropionate | 515.4088 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 516.3 | 5.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 517.01 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 517.33 | 4.84 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 517.33 | 4.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 517.34 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 517.38 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 518.32 | 4.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 518.32 | 5.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 518.37 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 518.37 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 518.73 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.29 | 5.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.29 | 5.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.32 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.37 | 0.88 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.4 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.4 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 519.4 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.31 | 5.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.32 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.33 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.34 | 4.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.34 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.34 | 5.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.37 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 520.4 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 521.34 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 521.42 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 521.42 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 521.42 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 522.2 | 9.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 522.35 | 5.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 522.42 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 522.43 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 522.43 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 523.42 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 523.43 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 524.36 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 524.36 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 524.43 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 524.45 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 525.04 | 6.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 525.28 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 525.45 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.26 | 5.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.26 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.31 | 6.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.41 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.41 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 526.41 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 527.15 | 9.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 527.28 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 527.3 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 527.38 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 528.18 | 5.87 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 528.42 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 529.35 | 1.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 529.42 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 530.44 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 530.79 | 8.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.34 | 1.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.36 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.36 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.36 | 1.29 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.4 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.42 | 0.96 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.44 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 531.69 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 532.02 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 532.36 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 532.44 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 533.38 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 533.38 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 533.45 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 534.31 | 5.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 534.38 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 534.41 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 534.41 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 534.52 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 535.4 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 535.4 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 536.42 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 536.43 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 537.19 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 537.41 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 537.41 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 538.42 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 538.42 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 538.42 | 1.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 538.44 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 538.44 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 539.29 | 6.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 539.3 | 13.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 539.43 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 539.43 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 540.36 | 5.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 540.36 | 5.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 540.37 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 540.37 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 540.44 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 541.38 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 541.44 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 541.45 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.32 | 5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.32 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.32 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.44 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.45 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 542.73 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 543.32 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 543.4 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 543.4 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 543.86 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 544.73 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 545.42 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 546.35 | 4.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 546.37 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 546.7 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 546.72 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.17 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.22 | 1.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.22 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.26 | 7.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.3 | 5.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.32 | 5.61 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.32 | 5.7 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.35 | 4.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.36 | 4.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 547.43 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 548.36 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 548.5 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 549.45 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 549.45 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.2 | 9.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.21 | 9.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.35 | 4.39 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.35 | 4.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 550.63 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 551.46 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 552.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 552.42 | 1.25 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 552.46 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 552.48 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 553.27 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 553.48 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 554.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 554.44 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 554.44 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 555.44 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 556.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 556.45 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 557.38 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 557.38 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 557.45 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 557.45 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 558.29 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 558.47 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 558.48 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 559.15 | 6.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 559.39 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 559.39 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 559.47 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 560.32 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 560.39 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 560.4 | 1.24 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 561.04 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 561.38 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 561.41 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 561.48 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 561.48 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 562.08 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 562.41 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 562.48 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 562.49 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 563.26 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 563.32 | 5.85 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 563.41 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 563.43 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.36 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.37 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.37 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.42 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.43 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.46 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 564.97 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 565.35 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 565.44 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 566.32 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 566.47 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 566.89 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 566.91 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 567.46 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Nelfinavir | 568.3255 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 568.39 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 568.39 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 568.48 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 568.48 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 569.41 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 569.47 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 569.97 | 7.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 570.35 | 4.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 570.48 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 571.43 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 571.49 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 573.45 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 574.43 | 4.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 574.43 | 4.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 574.47 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 574.48 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 575.29 | 7.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 575.47 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 575.72 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 576.05 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 576.39 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 576.49 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 576.49 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 576.51 | 1.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 577.48 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 577.51 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 577.51 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 578.39 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 578.39 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 578.49 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 578.51 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 579.49 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 579.51 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 579.51 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 580.51 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 581.24 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 581.3 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 581.51 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 581.52 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 582.24 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 583.25 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Biliverdin | 583.2526 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 583.32 | 6.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 584.06 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | UDP-galactose | 584.086 | 9.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 584.09 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 584.26 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 584.26 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 584.26 | 1.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 584.49 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.18 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 4.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 5.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 585.27 | 5.3 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 586.32 | 1.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 586.5 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 587.27 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 587.43 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 588.44 | 3.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 588.44 | 3.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 588.44 | 3.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 589.44 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 590.39 | 1.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 590.39 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 590.47 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 590.47 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 590.73 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 591.31 | 5.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 591.31 | 5.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 591.46 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 592.45 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 592.49 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 593.33 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 593.48 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 594.49 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 594.5 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 595.34 | 5.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 595.35 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 595.49 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 595.5 | 0.98 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 596.51 | 0.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 596.51 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 597.36 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 597.45 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 597.51 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 597.52 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 598.45 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 598.45 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 598.5 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 599.25 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 599.46 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 599.46 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 599.5 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.26 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.26 | 5.75 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.33 | 6.22 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.33 | 6.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.33 | 8.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.47 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 601.48 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 603.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 603.3 | 5.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 603.3 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 603.3 | 5.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 604.35 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 604.35 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 604.4 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 604.79 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 605.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 605.07 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 605.4 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 605.55 | 5.52 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 606.06 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 606.35 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 606.47 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.16 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.16 | 9.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.16 | 9.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.25 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 607.25 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.06 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.16 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.17 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.25 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.38 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 608.49 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 609.05 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 609.14 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 609.16 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 610.5 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 610.57 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 611.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 612.41 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 612.5 | 1.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 612.52 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 612.91 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Glutathione (oxidized) | 613.1558 | 9.9 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 613.44 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 613.5 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 613.51 | 1.01 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 614.53 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 615.17 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 615.46 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 616.46 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 616.46 | 1.21 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 616.54 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 617.47 | 1.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 617.48 | 1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 618.5 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 619.49 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 619.5 | 1.2 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 619.74 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 620.08 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 620.36 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 620.48 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 620.5 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 623.13 | 9.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 623.13 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 623.31 | 6.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 623.45 | 1.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Uridine-5-diphosphoacetylglucosamine | 625.1119 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 626.69 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 627.13 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 627.53 | 5.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 627.82 | 6.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 628.51 | 1.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 628.69 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 629.12 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 629.15 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 629.15 | 9.64 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 629.15 | 9.78 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 629.23 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 630.13 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.12 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.12 | 9.62 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.13 | 9.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.13 | 9.74 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.33 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 631.45 | 1.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 632.43 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 633.15 | 1.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 633.25 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 633.45 | 1.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 633.46 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 633.47 | 1.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 634.42 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 634.87 | 7.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 634.89 | 7.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 634.93 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 635.49 | 1.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 637.15 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 638.1 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 638.1 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 638.14 | 8.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 638.6 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 640.53 | 1.1 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 640.55 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 641.1 | 9.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 643.18 | 8.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 647.64 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 648.38 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 649.43 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 649.66 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 650.43 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 650.43 | 1.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 651.44 | 5.09 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 651.44 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 652.41 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 655.15 | 8.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 656.07 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 656.35 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 656.44 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 658.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 660.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 660.13 | 8.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 662.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 664.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | beta-Nicotinamide adenine dinucleotide | 664.1144 | 9.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 665.24 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 666.61 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 666.63 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 668.87 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 671.21 | 8.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 673.66 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 675.67 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 676.54 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 677.69 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.33 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.44 | 1.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.45 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.47 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.49 | 1.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 678.95 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 679.51 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 680.52 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 684.56 | 1.12 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 687.43 | 1.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 688.5 | 1.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 690.54 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 690.56 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 692.52 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 692.55 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 697.65 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 700.46 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 700.96 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 700.98 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 701.58 | 4.73 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 701.58 | 4.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 702.56 | 4.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 702.58 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 702.58 | 4.82 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 702.86 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 702.88 | 7.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 703.57 | 4.32 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 703.7 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 704.52 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 704.57 | 4.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 704.58 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 705.52 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 705.57 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 705.58 | 4.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 707.22 | 8.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 707.54 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 709.07 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 710.65 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 711.07 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 712.65 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 713.06 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 714.6 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 715.06 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 716.52 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 716.56 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 717.06 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 718.53 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 718.53 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 718.57 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 719.05 | 6.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 719.53 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 719.57 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 720.58 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 722.47 | 1.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 722.98 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 723.66 | 1.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 723.67 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 724.52 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 724.54 | 1.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 725.57 | 4.76 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 726.55 | 4.69 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 726.56 | 4.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 728.55 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 728.59 | 1.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 730.53 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 730.57 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 732.57 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 732.6 | 4.68 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 732.61 | 4.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 733.55 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 733.57 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 734.75 | 10.02 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 736.54 | 4.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 736.54 | 4.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 736.57 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 736.85 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 743.57 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 744.49 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 744.55 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 744.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 744.99 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 746.57 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 747.61 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 748.57 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 750.54 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 750.56 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 750.56 | 3.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 750.56 | 3.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 750.56 | 3.71 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 754.53 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 756.57 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 757.55 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 758.56 | 1.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 758.56 | 4.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 758.56 | 4.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 758.57 | 4.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 759.57 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 3.86 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 3.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 3.99 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 4.11 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 4.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.58 | 4.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 760.59 | 4.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 761.59 | 4.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 766.5 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 766.56 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 767.01 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 770.6 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 770.85 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 770.85 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 771.6 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 771.64 | 1.03 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 772.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 772.61 | 1.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 773.28 | 1.06 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 776.57 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 776.58 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 776.59 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 780.55 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 782.59 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 783.57 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 785.58 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 785.65 | 4.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 785.65 | 4.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 785.66 | 4.67 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | Flavin-adenine-dinucleotide | 786.1602 | 9.31 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
| AN002017 | 786.59 | 1.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 786.6 | 4.26 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 787.42 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 787.67 | 4.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 788.52 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 788.54 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 788.61 | 4.27 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 788.61 | 4.33 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 788.61 | 4.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 789.01 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 790.55 | 5.37 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 792.55 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 792.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 792.6 | 1.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 794.29 | 8.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 794.6 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 794.61 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 795.59 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 796.6 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 796.61 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 796.62 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 798.59 | 1.41 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 798.6 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 800.61 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 804.55 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 804.84 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 807.56 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 808.58 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 809.4 | 7.81 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 810.54 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 810.6 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 810.6 | 4.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 811.03 | 1.43 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 811.66 | 4.38 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 811.66 | 4.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 811.66 | 4.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 813.68 | 4.23 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 813.68 | 4.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 813.68 | 4.83 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 814.63 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 814.65 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 814.68 | 4.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 816.65 | 1.19 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 816.65 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 818.6 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 820.61 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 822.63 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 830.56 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 832.55 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 832.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 833.04 | 1.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 833.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 835.58 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 836.61 | 1.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 837.54 | 5.28 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 837.54 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 838.55 | 5.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 838.63 | 1.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 838.83 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 838.84 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 846.75 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 848.77 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 849.77 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 850.78 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 852.56 | 5.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 854.56 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 854.56 | 1.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 854.57 | 5.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 855.06 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 863.56 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 872.83 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 872.83 | 7.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 874.78 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 876.56 | 5.4 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 876.56 | 5.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 876.57 | 1.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 876.8 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 877.27 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 877.8 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 878.57 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 878.57 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 879.74 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 880.57 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 880.59 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 885.54 | 5.51 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 887.56 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 888.56 | 5.46 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 896.76 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 898.77 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 899.25 | 9.56 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 899.25 | 9.63 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 899.79 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 900.8 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 901.8 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 902.57 | 5.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 902.81 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 902.83 | 0.94 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 903.57 | 5.42 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 904.59 | 5.35 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 904.59 | 5.45 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 904.59 | 5.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 906.82 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 907.61 | 5.47 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 908.61 | 5.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 909.54 | 5.36 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 909.54 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 910.63 | 5.49 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 921.22 | 9.6 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 921.22 | 9.65 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 922.77 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 924.27 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 926.27 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 928.59 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 930.19 | 9.57 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 930.6 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 932.61 | 5.44 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 940.82 | 7.5 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 943.19 | 9.66 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 962.53 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 964.53 | 6.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 974.81 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 991.67 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 991.67 | 5.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 998.28 | 0.93 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1000.28 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1005.68 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1005.68 | 5.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1013.65 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1014.66 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1015.67 | 5.07 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1015.67 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1016.68 | 5.18 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1029.68 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1029.69 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1031.7 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1033.71 | 5.13 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1037.65 | 5.08 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1037.65 | 5.17 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1039.67 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1039.67 | 5.16 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1041.68 | 5.15 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1042.68 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1042.8 | 7.59 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1043.69 | 5.14 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1043.7 | 5.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1046.5 | 6.8 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1048.49 | 6.79 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1070.75 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1072.3 | 0.92 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1098.78 | 0.95 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1110.78 | 7.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1153.72 | 6.34 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1168.52 | 1.05 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1169.36 | 9.55 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1169.53 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1178.76 | 7.48 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1178.76 | 7.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1178.77 | 7.58 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1191.51 | 1.04 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1192.09 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1194.09 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1196.08 | 6.53 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells | |
| AN002017 | 1198.08 | 6.54 | Minutes | ST001211 | POSITIVE | Agilent 6530 QTOF | HILIC | Human | Cultured cells |
